GLPwatch
Novo sets sights on obesity market with diabetes drug.
Nat Biotechnol · 2014
Last updated 2026-05-28| Journal | Nat Biotechnol, 2014 |
|---|---|
| Citations | 0 |
| Relative citation ratio | 0.00 |
| NIH percentile | 0 |
| Molecules | — |
| Conditions studied | Obesity, Type 2 Diabetes |
Full record and abstract on PubMed 25380424 ↗